Domingo 19 de Noviembre 2017

CORRECTING and REPLACING Americord Announces the Appointment of Dr. Aasawari Bapat as Advisor, Global Stem Cell Product Development

NEW YORK–(BUSINESS WIRE)–#Americord–Please replace the release with the following corrected version due to
multiple revisions.

The corrected release reads:

AMERICORD ANNOUNCES THE APPOINTMENT OF DR. AASAWARI BAPAT AS ADVISOR,
GLOBAL STEM CELL PRODUCT DEVELOPMENT

Americord, the fastest growing cord blood bank in the country, and a
leader in the advancement of umbilical cord blood, cord tissue, and
placenta tissue banking, has appointed Dr. Aasawari Bapat as Advisor,
Global Stem Cell Product Development.

Dr. Bapat is an expert in the field of stem cell banking, transplants,
and transfusions and an International Ambassador for the American
Association of Blood Banking (AABB). She has over 15 years of experience
in quality management, regulatory affairs, and lab accreditations for
cord blood and adult stem cell banks, hospitals, and medical labs.

Throughout her career, Dr. Bapat has been instrumental in the successful
start-up, accreditation, and management of cord blood banks in US,
Australia, Middle East, Southeast Asia and India. She is trained in all
the leading cord blood banking industry standards, including AABB, ISO,
CAP, JCI, AABB, FACT, FDA, OSHA, and MOH.

“We are thrilled to have Dr. Bapat join the Americord team as our
Advisor, Global Stem Cell Product Development,” commented Martin
Smithmyer, CEO of Americord. “As we continue to grow, her expertise will
be invaluable in ensuring we operate to the highest quality standards
and deliver the best possible outcomes for our clients.”

Prior to joining Americord, Dr. Bapat served as Director of Quality and
Regulatory Affairs for InfoHealth Global in Dubai, UAE, an international
leader in organizational accreditation, global regulatory compliance,
and quality management services for cellular based treatment programs
and storage facilities. She holds an MD in Clinical Pathology and
Bacteriology.

About Americord Registry (“Americord”)

Americord Registry is a leader in the advancement of umbilical cord
blood, cord tissue and placenta tissue banking. Americord collects,
processes, and stores newborn stem cells from umbilical cord blood for
future medical or therapeutic use, including the treatment of more than
80 blood diseases such as sickle cell anemia and leukemia. Founded in
2008, Americord is registered with the FDA and operates in all 50
states. The company’s laboratory is CLIA Certified, accredited by the
AABB and complies with all federal and state guidelines and applicable
licenses. Americord is headquartered in New York, NY. For more
information, visit www.americordblood.com.

Contacts

Americord
Alysha Bullock, 866-503-6005
alysha@americordblood.com